Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT

Secondary failure of platelet recovery (SFPR) is a life-threatening complication that may affect up to 20% of patients after allogeneic hematopoietic stem cell transplantation (HSCT). In this study, to evaluate the efficacy of recombinant human thrombopoietin (rhTPO), we retrospectively analyzed 29...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yigeng, Wang, Mingyang, Shen, Biao, Zhao, Fei, Zhang, Rongli, Chen, Xin, He, Yi, Zhai, Weihua, Ma, Qiaoling, Wei, Jialin, Huang, Yong, Yang, Donglin, Pang, Aiming, Feng, Sizhou, Jiang, Erlie, Han, Mingzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761877/
https://www.ncbi.nlm.nih.gov/pubmed/35019756
http://dx.doi.org/10.1177/10760296211068037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761877/
https://www.ncbi.nlm.nih.gov/pubmed/35019756
http://dx.doi.org/10.1177/10760296211068037

Ejemplares similares